
Samantha Baxter
@SamBaxterCGC
Followers
679
Following
240
Media
21
Statuses
260
Licensed Genetic Counselor @ the Broad Institute. Interested in scaling clinical genomics, data sharing, & variant curation. Opinions expressed are my own.
Joined October 2012
Thank you to @ChanZuckerberg for the opportunity to talk about the Rare Genomes Project ( and tell the story of GeniE (.
The Rare Genomes Project, driven by patient communities and tech like GeniE, is turning resilience into action. Learn how:
0
1
2
@ChanZuckerberg A special thank you to Nick Watts, Riley Grant & Josephine Lee for lending their software development expertise to this tool. Finally, thank you to @HeidiRehm and @AnneOtation for their support and belief in GeniE from the very beginning!! (4/4).
0
0
6
Thank you to everyone who contributed to this project (, but especially our co-developers @ChanZuckerberg #RareAsOne Network. This tool was inspired by the rare disease advocacy community and I am so grateful to count you all as collaborators (3/4).
1
0
4
This release is 6 years in the making! I am so excited to finally share GeniE, the genetic prevalence estimator. By removing the need for computational expertise, GeniE makes estimating genetic prevalence more standardized and accessible (1/4)
GeniE, the genetic prevalence estimator, is now available! This tool allows users to estimate the genetic prevalence of autosomal recessive diseases using #gnomAD allele frequency data & classifications from #ClinVar. Blog post:
3
10
38
RT @gnomad_project: gnomAD 4.1 is now live! This release fixes the AN issue in #gnomAD v4.0 & adds 2 new functionalities:.1) Joint AN acros….
0
27
0
RT @broadinstitute: Today is #GeneticCounselorAwarenessDay! Genetic counselors are crucial members of our Broad community, and while we app….
0
2
0
RT @gnomad_project: Gene constraint is now available on #gnomAD v4! This is the first time we have had constraint data available on GRCh38.….
0
11
0
#gnomad v4 is finally live! 3 years of work and it’s finally here!!! Now the fun part begins. I can’t wait to dive in and see what the power of this dataset can do…well…maybe first some sleep…but then my 2nd favorite thing, kicking off some long awaited analyses #genechat.
The #gnomAD team is proud to announce the release of gnomAD v4! The v4 dataset includes 730,947 exomes & 76,215 genomes, which is ~5x larger than the v2 & v3 releases combined, & includes nearly 120K indivs of non-European genetic ancestry #ASHG23 (1/11)
0
1
17
RT @AnneOtation: With loss of function (LoF) variation, all may not be as it seems. Led by Moriel Singer-Berk, @s_gudmundsson, and @HeidiRe….
0
28
0
Years of work finally making it out to the community. Congrats to my co-authors, especially Moriel Singer-Berk, @s_gudmundsson @AnneOtation and @HeidiRehm!.
📢New @AJHGNews .📰Advanced variant classification framework reduces the false positive rate of predicted loss-of-function variants in population sequencing data.🧑🤝🧑@anneotation @HeidiRehm @s_gudmundsson & colleagues.👇.
0
1
6
An inspiring piece by @TaniaSimoncelli highlighting what is able to be achieved when you put patients at the center of research! I am forever inspired by the #rareasone groups and will always be grateful for the opportunity to work with them.
Centering patient communities leads to unique insights + perspectives that can only come from day-to-day knowledge of #RareDisease. Read more from @cziscience’s @TaniaSimoncelli on how we’re supporting patient-led research.#RareAsOne
1
2
7
RT @TANGO2Research: Meet Ryan! . "What became clear. is that not nearly enough is known about how it is that TANGO2 mutations. That is….
0
3
0
@TANGO2Research @cziscience Congrats to #ChristinaMiyake , @SeemaLalani, all their coauthors, and the patients/families who made this possible.
1
0
2
Excited to share this publication, which includes the genetic prevalence estimates for TANGO2. Our partnership with @TANGO2Research was one of our first collaborations with @cziscience #RareAsOne community. It’s an honor to help move their mission forward
1
4
9
If you work in #RareDisease please read this. Jocelyn beautifully summarizes the challenges rare families face to find a treatment/cure. While progress is happening, we need to do more. “We have the power to change the story of Rare” @CureCMT4J #genechat
1
0
3
Moderating the @broadinstitute #RareDiseaseDay panel was an honor. There was so much I took away from this event but I absolutely agree with these top 3. #partnerwithpatients.
@YaelWei59680589 @broadinstitute So many great takeaways from today’s event. Our top 3: .1/There are many ways to meaningfully collaborate with patient groups on drug development. 2/Patient groups are powerful research drivers. 3/Researchers are eager to partner with patient communities.
0
0
13
Most of my career I didn’t feel like “a real GC”. There was some vision of the perfect GC and I didn’t meet the mark. I know there are others who question their own “GC-ness”. #GCAD2022 feels like a good day to say Don’t Listen to That Voice #YouAreAGeneticCounselor (2/2).
2
0
18
I haven't had a traditional GC career, but the path I have taken is mine, & I love it. Today I am an ops manager/council member @gnomad_project, a policy co-chair @GREGoR_research, & a researcher partnering w/ patient organizations @cziscience and #IAmAGeneticCounselor (1/2).
3
2
43